tert-Butyl (3-aminocyclobutyl)(methyl)carbamate

Catalog No. :
ACLRMB902
CAS No. :
1392803-87-0
Molecular Formula :
C10H20N2O2
Molecular Weight :
200.28

IUPAC Name:tert-butyl (3-aminocyclobutyl)(methyl)carbamate

tert-Butyl (3-aminocyclobutyl)(methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$123.00Login to see priceInquiryInquiry
100mg95%$173.00Login to see priceInquiryInquiry
250mg95%$242.00Login to see priceInquiryInquiry
1g95%$572.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-aminocyclobutyl)(methyl)carbamate
IUPAC Nametert-butyl (3-aminocyclobutyl)(methyl)carbamate
MDL No.MFCD23106177
Molecular FormulaC10H20N2O2
Molecular Weight200.28
SMILESO=C(OC(C)(C)C)N(C1CC(N)C1)C
InChI KeyOMNOXYPUAHSJRZ-UHFFFAOYSA-N
Synonymtert-butyl N-(3-aminocyclobutyl)-N-methylcarbamate | 1392803-87-0 | 1392803-27-8 | 1392803-14-3 | tert-Butyl N-(trans-3-aminocyclobutyl)-N-methylcarbamate | tert-Butyl N-(cis-3-aminocyclobutyl)-N-methylcarbamate | cis-tert-Butyl-3-aminocyclobutyl(methyl)carbamate | ter
CAS No.1392803-87-0
PubChem CID72207771

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLRMB902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLRMB902 route product structure diagram
    ACLRMB9021392803-87-0
Inquiry

2. ACLRMB902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLRMB902 route product structure diagram
    ACLRMB9021392803-87-0
Inquiry

Comments (0)